Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

May 30, 2023 4:07 (London Time)

Horizon Therapeutics

Youtube Subscribe

...

Sector: Pharmaceuticals
Ticker: HZNP
Sentiment: -0.7845
MarketCap: 25,531,351,162.0
High: 100.13 Low: 99.32

Open: 99.69 Close: 99.61 Change: -0.08

Are you still looking for information about Horizon Therapeutics Company Inc? An AI summarized it for you.

Are looking for the most relevant information about Horizon Therapeutics? Investor spend a lot of time searching for information to make investment decisions in Horizon Therapeutics. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Horizon Therapeutics are: Horizon, Therapeutics, HZNP, Theraputics, Public, FTC, block, and the most common words in the summary are: horizon, therapeutic, stock, plc, company, hznp, news, . One of the sentences in the summary was: Federal Trade Commission (FTC) yesterday said it will block the acquis.. …

Concept Map

...

Semantic Network

...

Stock Summary

Horizon Therapeutics Public Limited Company focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. Its portfolio comprises 12 medicines in the areas of rare diseases.

Today's Summary

Fidelity National Information Services, Inc. increased its holdings in Horizon Theraputics Public by 1.8% during the 2nd quarter. Federal Trade Commission (FTC) yesterday said it will block the acquis.

Today's News

Horizon Therapeutics manager, statistical programming - horizon therapeutics. Manager, Statistical Programming - Horizon Theraputics Monster Find Jobs Salary Tools. StockNews.com began coverage on shares of Horizon Therapeutics Public in a report on Sunday. Fidelity National Information Services, Inc. increased its holdings in Horizon Theraputics Public by 1.8% during the 2nd quarter. Shares sold by SVB Wealth LLC. Horizon Therapeutics PLC has on average historically risen by 70.6% over the next 52 weeks based on the past 11 years of stock performance. The current trend is considered strongly bearish and HZNP is experiencing slight selling pressure. Horizon Therapeutics PLC (HZNP) stock is trading at $100.28 as of 2:56 PM on Tuesday, May 23, a drop of -$0.29, or -0.30% from the previous closing price of $100. The Federal Trade Commission (FTC) yesterday said it will block the acquis. Federal Trade Commission said on Tuesday it has filed a lawsuit to stop Amgen Incs $27.8 billion acquisition of Horizon Therapeutics Plc in a rare move to block a large pharmaceutical deal. FTC is preparing to seek an injunction in federal court that would prevent the deal from closing. FTC sues to block Amgens $27.8 billion deal to acquire Horizon Therapeutics. Judge who will decide if Amgen can go forward with its purchase of Horizon Theraputics (HZNP) Judge considering hearing on matter in September. Horizon Therapeutics Public Limited Limited Company (HZNP) rose in Q4 on acquisition news. TheStreets report on Monday, May 8th, which downgraded the companys rating from a “b-” to a c+”

Stock Profile

"Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. Its portfolio comprises 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation. It markets TEPEZZA (teprotumumab-trbw) for intravenous infusion; KRYSTEXXA (pegloticase injection) for intravenous infusion; RAVICTI (glycerol phenylbutyrate) oral liquid; PROCYSBI (cysteamine bitartrate) delayed-release capsules and granules for oral use; ACTIMMUNE (interferon gamma-1b) injection for subcutaneous use; BUPHENYL (sodium phenylbutyrate) tablets and powder for oral use; QUINSAIR (levofloxacin) solution for inhalation; and UPLIZNA (inebilizumab-cdon) injection for intravenous use. The company also markets PENNSAID (diclofenac sodium topical solution) for topical use; DUEXIS (ibuprofen/famotidine) tablets for oral use; RAYOS (prednisone) delayed-release tablets for oral use; and VIMOVO (naproxen/esomeprazole magnesium) delayed-release tablets for oral use. It has collaboration agreements with HemoShear Therapeutics, LLC; Alpine Immune Sciences, Inc.; Halozyme Therapeutics, Inc.; Arrowhead Pharmaceuticals, Inc.; Q32 Bio Inc.; and Xeris Biopharma Holdings, Inc. The company was formerly known as Horizon Pharma Public Limited Company and changed its name to Horizon Therapeutics Public Limited Company in May 2019. Horizon Therapeutics Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland."

Keywords

This document will help you to evaluate Horizon Therapeutics without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Horizon Therapeutics are: Horizon, Therapeutics, HZNP, Theraputics, Public, FTC, block, and the most common words in the summary are: horizon, therapeutic, stock, plc, company, hznp, news, . One of the sentences in the summary was: Federal Trade Commission (FTC) yesterday said it will block the acquis.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #horizon #therapeutic #stock #plc #company #hznp #news.

Read more →

Related Results

...
September 24, 2023 10:22 (London Time)

Horizon Therapeutics

Federal Trade Commission cleared Amgen to proceed with its $27.8 billion acquisition of Horizon Therapeutics. Percentage of shares that are sold sho…
Sector: Pharmaceuticals
Ticker: HZNP
Sentiment: 0.8583
MarketCap: 26,448,872,604.0
High: 115.7 Low: 115.51

Open: 115.56 Close: 115.61 Change: 0.05

Read more →
...
April 28, 2023 18:05 (London Time)

Horizon Therapeutics

Horizon Therapeutics (NASDAQ: HZNP) operates as a biotechnology company. 75 hedge fund portfolios held Horizon Therapedutics Public Limited Company …
Sector: Pharmaceuticals
Ticker: HZNP
Sentiment: 0.5868
MarketCap: 25,494,796,288
High: 112.14 Low: 111.15

Open: 111.15 Close: 111.6 Change: 0.45

Read more →
...
May 30, 2023 4:07 (London Time)

Horizon Therapeutics

Fidelity National Information Services, Inc. increased its holdings in Horizon Theraputics Public by 1.8% during the 2nd quarter. Federal Trade Comm…
Sector: Pharmaceuticals
Ticker: HZNP
Sentiment: -0.7845
MarketCap: 25,531,351,162.0
High: 100.13 Low: 99.32

Open: 99.69 Close: 99.61 Change: -0.08

Read more →